Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Atherosclerotic Cardiovascular Disease Risk Assessment

Atherosclerotic Cardiovascular Disease Risk Assessment

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

Measures of disease severity in eosinophilic esophagitis (EoE)

Take a Stand Against Influenza: Focus on Cardiovascular Disease Patients

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.